WO1995033994A1 - Method and apparatus for flow control - Google Patents
Method and apparatus for flow control Download PDFInfo
- Publication number
- WO1995033994A1 WO1995033994A1 PCT/US1995/002431 US9502431W WO9533994A1 WO 1995033994 A1 WO1995033994 A1 WO 1995033994A1 US 9502431 W US9502431 W US 9502431W WO 9533994 A1 WO9533994 A1 WO 9533994A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- flow
- fluid
- porous substrate
- sizing material
- pad
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/525—Multi-layer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
Definitions
- the present invention relates to methods and apparatus for controlling the flow of fluids through a substrate such as a pad or filter, particularly for use in clinical assay devices.
- cholesterol is an analyte of importance.
- total blood cholesterol mainly the LDL fraction
- coronary artery 'disease J.A.M.A. 253: 2080-2086, 1985.
- New guidelines have been established for adults to identify risk groups associated with blood cholesterol levels. Since cholesterol levels can be controlled by both diet and cholesterol-lowering medications, it is useful for those individuals at risk to be able to monitor their own cholesterol at home in order to reduce the potential for heart disease.
- the measurement of other naturally occurring compounds of physiological importance, such as glucose, lipoproteins, etc., as well as synthetic drugs, is also of great interest.
- enzymes are often used as labels in immunoassays.
- an enzyme is covalently conjugated with one component of a specifically binding antigen- antibody pair, and the resulting enzyme conjugate is reacted with a substrate to produce a signal which is detected and measured.
- the signal generated by the enzyme in either the conventional chemical assay or the immunoassay, may be a color change, and the color change may be detected with the naked eye or by a spectrophotometric technique.
- a disposable assay device should include a means to delay the flow of the sample through the device for a predetermined time to permit incubation of the sample with the reagents or indicators present in a particular region of the device. After the incubation period, which is generally on the order of a few minutes or less, the sample then flows to the next region of the device for further processing.
- An ideal flow delay means should work like a valve, with a "closed” and an “open” state. When the state is “closed”, the fluid flow should stop, and when the state switches to “open”, the fluid should flow through the flow-delay valve with little or no restriction, and the flow rate of the fluid through the device should be unchanged.
- a wide range of disposable analytical devices has been developed which include means to control flow of fluids therethrough. However, none of these previously developed devices has a flow-delay means with a valve-like effect on the flow of fluids.
- Deutsch et al. in U.S. Patent No. 4,522,923, disclose a test device comprising a container having at least two water- soluble barriers between at least three superposed chambers. Upon introduction of an aqueous biological sample to be tested into the topmost chamber, the sample will successively mix with the contents of the chambers. The contact time in each chamber is a function of the water solubility of the barriers.
- Ebersole in U.S. Patent No. 4,522,786, discloses a multilayer test device comprising at least two liquid permeable functional layers superposed upon one another, the layers in liquid communication, with a barrier layer separating the layers.
- the barrier layer is a chemically inert, liquid insoluble, foraminous septum, the foramina of which are filled with a thermally sensitive material which is liquid impermeable at assay temperatures but capable of melting when heated to provide rapid liquid communication between the function layers. This melted material then travels through to the next layer with the test liquid.
- Vonk in U.S. Patent No. 5,185,127, discloses a device for assaying an analyte comprising an enclosure and a filter stack. Flow control is provided by a hydrophilic membrane which contains a binder for an analyte. This membrane is impervious to the passage of an aqueous liquid until activated by a wetting agent. Johnston et al., in U.S. Patent No.
- 4,038,485 disclose a test composition for detecting a component in a sample which comprises a reactant system which, upon contact with the sample, interacts with the component to produce a detectable response, as well as an inhibitor system which, upon contact with the sample, prevents the reactant system from interacting with the component after lapse of a predetermined time.
- Amano et al. in U.S. Patent No. 4,889,797, disclose a dry analytical element for assaying enzyme activity in a liquid comprising a support having provided thereon at least a porous liquid-spreading layer composed of fibers which do not absorb water.
- flow control is directed to decreasing spreading of the liquid within a layer rather than through a layer.
- Deneke et al. in U.S. Patent No. 4,876,076, disclose an assay device comprising a first carrier layer having applied thereto a liquid absorbing layer and a separate second movable carrier having applied thereto a dissolvable reagent-containing layer which is not in initial contact with the first carrier layer.
- the reagent-containing layer is dissolved by contact with a liquid contained in the liquid absorbing layer, and the first carrier layer is positioned in the device to permit contact between the liquid absorbing layer and the reagent- containing layer by applying pressure to one of the carrier layers.
- Flow of sample from one layer to another is controlled by bringing the two carrier layers into contact with each other so that the sample is transferred.
- This type of flow control is also shown in Ra el et al., U.S. Patent No. 4,959,324, in which a flow path is completed by moving a sample receiving pad into a gap between two assay strips.
- Woodrum in U.S. Patent No. 4,959,305, discloses a multizone test device for immunoassays in which assay reagents are reversibly immobilized within the various layers of the device.
- the binding interactions within the device depend upon the interactive properties of and between the assay reagents and the matrix comprising the incorporating layer of the reversibly immobilized assay reagents, and the disruptive properties of the liquid test sample necessary to disrupt the particular reversible binding interaction between the assay reagents and the matrix to release and render useable the reagents in an analytically effective amount within the device.
- Hydration and expansion of a compressed foam switching element permit automatic timed sequential delivery of multiple reagents in a device disclosed by Bruce et al. in Analytical Chemical Acta 249 (1991) . 263-269. This technique is not well- suited for devices that require no diluent and which are sensitive to the total volume of sample fluid required.
- Liquid flow through a filter can also be controlled by reactions between the sample and a component of the filter, cf. U.S. Patent No. 5,217,905, to Marchand et al. Similarly,
- Tanaka et al. in U.S. Patent No. 4,966,784, disclose inhibiting migration of a water-soluble indicator in a reagent layer in an assay device by using a particular organic solvent.
- Liotta in U.S. Patent No. 3,723,064, discloses a layered testing device including a first porous layer impregnated with a reagent system which reacts with the analyte to produce an end product.
- a membrane having plural regions with differing permeabilities is adjacent to the first porous layer. The permeability differences are obtained either by impregnating the regions with different concentrations of a chemical reactive with the end product, or by varying the pore size in the regions.
- the amount of sample applied to the test strip is metered, rather than the amount of sample fluid that is retained for a predetermined time within a selected area of a test device.
- Other workers have coated filters with a variety of coatings to alter conditions within the filter, none of which provides a valve-like action to control the flow of fluid:
- a layer for controlling diffusion rate of sample through the device can be provided by varying the formulation ratio of a hydrophobic polymer and a hydrophilic polymer which constitute the layer, as shown by Koyama et al., U.S. Patent
- Patent No. 4,587,099 disclose a test strip which includes a slowly absorbent layer for sucking up a fluid sample. This layer is slowly absorbent rather than a layer which retains a liquid for a predetermined period of time.
- a flow-delaying polymer on an immunoassay filter is shown in Nelson, U.S. Patent No. 4,923,680. Blood clotting has been used to inhibit sample flow through a track in Lucas, U.S. Patent No. 5,207,988.
- 5,089,383 disclose a heterogeneous immunoassay in which the production of the signal is temporarily delayed by using an inhibitor which can be an alternate substrate for the enzyme signal or a compound which reacts with the product of the enzyme and its substrate.
- Terminiello et al. inU.S. Patent No. 4,774,192, disclose a dry chemistry reagent system comprising a porous membrane of essentially uniform composition which has a porosity gradient from one planar surface thereof to the other.
- uroda et al. in U.S. Patent No. 4,416,777, disclose a material for separating leukocytes from a leukocyte-containing suspension which comprises a fibrous material having a surface layer coated on the fibrous material which can be dissolved by degrees in water.
- Alkyl ketene dimers have been used for many years as reactive alkaline sizing agents in the paper industry. Industrially, alkyl ketene dimers are added to the "wet end" of the papermaking process, that is, the slurry of bleached pulp in water that is at the very start of the papermaking process. Aqueous alkyl ketene dimer emulsions, which contain alkyl ketene dimer and additives such as defoamers and biocides, have been developed and marketed for this application. Wet-end addition allows for thorough deposition of the alkyl ketene dimer throughout the cellulose fiber, and is a less costly process than post-treatment of the fibers.
- Gupta et al. in U.S. Patent No. 5,071,675, disclose sizing cellulose fibers by applying a solution of alkyl ketene dimer in ethanol to cellulose fibers.
- Kortmann et al. in U.S. Patent No. 5,028,236, disclose treating wool and synthetic polyamide materials with ketene dimers.
- Dereser in U.S. Patent No. 4,241,136, discloses a cationic size composition for glass fibers based upon a cationic film-forming polymer which also includes an alkylketene dimer.
- the coated glass fibers are then coated with an anionic size composition containing an anionic film-forming polymer whereby the cationic and anionic polymers react to form a thin film on the glass fibers.
- sizing materials that can be applied to fibrous substrates, such as pads, so as to provide a flow delay means with a valve-like effect on the flow of fluids.
- the retention period can range from less than one minute to more than 20 minutes, depending upon the fluid, the impregnant or coating (sizing) material, and the amount of impregnant or coating material applied to the substrate.
- a sizing material is a material which is applied to a surface to change the properties of the surface. More particularly, in the present invention the sizing material inhibits the absorption of fluids onto the surface which has been treated with the sizing material for a predetermined period of time.
- a flow control means is a substrate which has been treated, coated, or impregnated with a sizing material which retains a liquid sample in the substrate for a predetermined period of time, after which time substantially all of the liquid sample flows through the substrate.
- the sizing material is preferably an alkyl ketene dimer.
- sizing materials that can be used in the present invention as sizing materials include fatty acid chlorides and fluorocarbon resins.
- the flow control means of the present invention has the following features and advantages:
- the degree of flow control means is readily metered by the amount of sizing material applied to the substrate.
- coated or impregnated substrates are self- regulating, and require no designed-in moving parts and no input from the user for accurate operation.
- the delay times obtained are highly reproducible.
- the sizing materials used for flow delay are inexpensive and are easily and accurately dispensed onto the substrate material.
- the sizing materials do not chemically affect reagents used in clinical assays.
- the sizing materials used do not affect the viscosity of the reagent fluid and thus do not affect the flow of the reagent fluid or the run time of the reagent strip portion of the device.
- Some of the sizing materials can be covalently attached to the substrate, particularly if the substrate is paper or a surface-modified glass fiber material.
- Figure 2 shows how alkyl ketene dimer sizes a matrix.
- Figure 3 shows sizing of a matrix with a fluorocarbon resin.
- Figure 4 shows how compounds having both hydrophilic and hydrophobic domains coat a matrix surface.
- Figure 5 shows configuration for flow delay pads for assay devices.
- Figure 6 illustrates an assay device incorporating a flow- delay layer.
- Figure 7 illustrates flow delay times for a variety of saturated alkyl ketene dimers.
- Figure 8 illustrates flow delay times for monounsaturated alkyl ketene dimers.
- the present invention provides a coating of a sizing material on a substrate to inhibit flow of a liquid through the substrate fox a predetermined period of time. After a predetermined period of time, the liquid is completely released through the substrate. There is substantially no effect on the viscosity and flow characteristics of the fluid nor on the chemical composition of the fluid.
- the rate of flow delay i.e., the length of time the liquid is retained on the substrate, is controlled by the amount of sizing material applied to the substrate. Thus, one can control the length of time that the flow is delayed by varying the type and amount of sizing material.
- the control means is self-regulating.
- a sizing material is applied to a pad made of paper, glass fiber, fabric, or similar porous materials to provide flow-control means for use in diagnostic devices. These pads retain fluid for a discrete period of time to enable substances in the fluid to react with components in the pad for a discrete period of time, after which the fluid flows completely through the pad. Different types of reactions that require different incubation times can all use the same type of pad with differing levels or different types of sizing material applied to correspond to the desired delay time. Unlike many coating materials heretofore used in assay device pads, the sizing materials do not chemically affect the reagent mixture, nor do they affect the viscosity of the sample or reagent fluid. The sizing materials of the present invention thus do not affect the flow of the reagent fluid or the run ⁇ time of a reagent strip portion of an assay device.
- flow delay means that the flow of a fluid through a material is delayed for a certain length of time, after which the fluid flows substantially completely through the flow delay.
- the flow rate is such that in this time period no more than 10%, and preferably no more than 5%, of the sample flows through the material.
- t c substantially all of the remainder of the sample passes through the flow delay material.
- the rate of flow after t governance should be substantially greater than the rate of flow before t c , as the sizing material does not increase the viscosity of the sample.
- t preferably ranges from 2 seconds to twenty minutes.
- t c more preferably ranges from about 2.5 seconds to about 5 minutes.
- the amount of sample retained in the flow delay material must be a sufficient amount of sample to be incubated in the flow delay material to effect a valid assay.
- the amount of sample which passes through the flow delay material must be a sufficient amount of sample to effect a valid assay.
- the flow delay means of the present invention acts like a timed valve, in that the fluid is retained in the flow delay means for a predetermined time, t c . After this time t c , the fluid flows substantially completely through the flow delay means, such as into an adjoining layer of an assay device.
- the flow delay means retains the fluid in the flow delay area only for a predetermined time, and then permits the fluid to flow through the flow delay means substantially without changing the fluid.
- the flow delay means does not affect the viscosity of the fluid, nor does the flow delay means add extraneous material to the fluid sample from the flow delay means.
- the fluid is free to flow directly through the flow delay means just as if a mechanical valve had been opened, and substantially all of the fluid flows through this "valve" without being retained in the flow delay means.
- One way of expressing the fluid flow through the flow delay means is in terms of the time required for the sample to pass completely through the flow delay means once the predetermined time, t c , has passed.
- the time period from initial contact of the fluid sample with the flow delay means, t 0 , to the predetermined time, as noted above, can be expressed as t c .
- the time required for the sample to flow through the flow delay means after t c can be expressed as t f .
- t f should not be much greater than t c , and may often be smaller than t c , depending upon the length of time the sample is retained by the flow delay device, the nature of the sample, and subsequent operations to be performed on the sample.
- t f can be from less than one minute to greater than five minutes, depending upon the initial viscosity of the sample, the rapidity with which the test must be conducted, and the like. On the other hand, if t c is 20 minutes, it may be useful for t f to be less than 20 minutes.
- t c and t f can be adjusted so that they are multiples of each other.
- One skilled in the art can readily determine the relationship between t c and t f which is optimum for the particular fluid sample to be treated, and can adjust the flow delay means accordingly.
- t c can be one minute and t f can be up to about ten minutes.
- t f can be a fraction of t c/ i.e., 5 minutes, or 1/4 t c .
- the relationship between t c and t f is not critical to the invention; the criticality is that the flow delay means act as a means to retain the fluid sample for a predetermined time, and then release the sample through the flow delay means.
- a great many sizing materials can be used to control the flow of liquids through substrates, depending upon the type of fluids used.
- these sizing materials include alkyl .ketene dimers, alkenyl succinic anhydrides, and fluorocarbon resins, either alone or with other materials such as saccharides, including mono-, di-, or oligosaccharides, including lactose, sucrose, glucose, etc.; low molecular weight polymers, generally of molecular weight of from about 500 to 20,000, such as polyethylene glycol (PEG) ; waxes and the like.
- PEG polyethylene glycol
- polymers include polyvinyl pyrrolidone, polyvinyl alcohol, modified soluble cellulosics such as carboxymethy1 eellulose , cellulose acetate, hydroxyethylcellulose, and the like, and proteinaceous polymers like gelatin. Since not all materials offer equivalent degrees of fluid retention, the sizing material and amount thereof used to coat or impregnate the substrate can be chosen to provide the desired flow delay time for the fluid to be controlled.
- a wide range of disposable analytical devices has been developed which can incorporate the flow delay device of the present invention. These devices incorporate all of the components needed for an assay in a wet or a dry format. Many of these devices receive samples of whole blood and perform blood separation, mixing, incubation, addition of reagents, and signal generation by one or more manipulation steps, optionally using small instruments. However, it is desirable to perform many assays using disposable devices which do not require instrumentation or additional equipment. Since chemical and enzymatic reactions often require incubation, an assay device in which an incubation step is required must have means to delay flow of fluid through the device in order to allow for proper incubation periods.
- the flow delay means should function like a valve, with both a closed state in which the fluid flow stops, and an open state, in which the fluid flows through the flow-delay means with little or no restriction. Once the flow delay means is in the open state, the flow rate of the fluid through the device should be unchanged.
- the flow delay means of the present invention can be used in assays for a great many different types of fluid samples.
- the fluid sample containing the analyte to be determined can be a naturally occurring or artificially formed fluid suspected of containing the analyte, such as a biological fluid.
- biological fluids such as blood, plasma, serum, urine, milk, saliva, amniotic fluid and cerebrospinal fluid.
- Other fluids which may be analyzed according to the present invention include water, surface and ground foods and beverages, diagnostic and pharmaceutical compositions, industrial compositions, and other fluids containing or suspected of containing analytes of interest.
- the analytes may be haptens or antigens, and include naturally-occurring compounds, synthetic compounds, or combinations thereof.
- the compounds may vary from methanol to high molecular weight proteins comprising a plurality of subunits.
- the compounds may be monomeric or polymeric.
- the assay devices of the present invention can be used to assay for a variety of commonly detected substances, including cholesterol, thyroxine, theophylline, glucose, albumin, ketones, bilirubin, occult blood, nitrite, urobilinogen, hydrogen ion concentration, uric acid, and the like.
- analytes of particular interest are those analytes involving both naturally occurring and synthetic drugs, particularly those used for treating chronic conditions, such as valproate, theophylline, barbiturates, etc., drugs of abuse, and the like.
- Other compounds of interest are those which are naturally occurring, particularly physiologically active compounds, such as hormones, growth factors, colony stimulating factors, interferons, surface membrane proteins, viral proteins, animal proteins, antibodies, enzymes, etc., both proteinaceous and non-proteinaceous.
- the conjugates which are prepared may be prepared in conventional ways, and will vary with the particular component which interacts with the enzyme and the nature of the analyte.
- analytes which serve as a substrate for an enzyme, resulting in a product which can further react with another compound to produce a detectable product, particularly a visually colored product, include galactose, glucose, cholesterol, urea, nicotinamide adenine dinucleotide, riboflavin, uric acid, and the like.
- Analytical Device and Methods One embodiment of the assay device of the present invention is illustrated in Figure 6.
- the sample 61 first contacts the absorbent pad 62. From the absorbent pad, the sample flows through to the reagent layer 63.
- the flow delay layer 64 is below the reagent layer so that the sample has time to incubate with the reagent(s) in the reagent layer. After a predetermined period of time, the flow delay layer opens, and the sample flows through to the measurement zone 65.
- the reagents used in assay devices according to the present invention are any reagents that react with the analyte of interest to produce a product which can give a detectable signal.
- reagents that react with the analyte of interest to produce a product which can give a detectable signal.
- galactose, glucose or other saccharides, cholesterol, urea, nicotinamide adenine dinucleotide, riboflavin, compounds which result in the reduction or oxidation of co-factors, such as NAD or NADP can be assayed with conventional reagents which produce known products.
- the resulting hydrogen peroxide may react in the presence of a peroxidase such as horseradish peroxidase, with a wide variety of horseradish peroxidase substrates.
- a peroxidase such as horseradish peroxidase
- substrates include o-chlorophenol benzidine, tetramethylbenzidine, dimethylaniline in conjunction with 3- methyl-2-benzothiazolinone hydrazone (MBTH) , dicarboxidine, o- dianisidine, 4-chloro-l- naphthol, and the like.
- the compounds which are bound to the assay measurement zone may react by themselves with the reagent- analyte product or in conjunction with a component in the transport medium.
- various reductants such as NADH, FMNH, etc.
- compounds which may be bound in the measurement region may include methylene blue, N-methyl phenazine methosulfate, ferrocene, ferridoxin, cytochrome c, triphenyltetrazolium, etc., preferably where the reduced compound is colored.
- Another format involves analytes which are not substrates of enzymes which produce a product which can be used to produce a detectable signal by reacting with another substance.
- analytes can be employed in a variety of ways where the analyte or analyte analog is joined to another compound which serves to modulate enzyme activity.
- co-enzyme conjugates can be prepared where the co-enzyme conjugate competes with the analyte for antibody to the analyte.
- the antibody bound conjugate will be unable to bind to the enzyme and no reaction will occur.
- Free co-enzyme conjugate will be able to bind and allow for a single reaction in the absence of a regeneration system.
- the device of the present invention can be used to monitor any solution comprising a first compound which by itself or by enzymatic transformation reacts with another compound to produce a signal resulting in a detectable boundary in the measurement zone. Therefore, any methodology which provides such a first compound can be monitored.
- rate measurements can be made, where the reaction does not continue in a significant manner once transferred to the sample pad. Alternatively, the reaction is terminated so that no further reaction occurs, and then this solution is used for impregnating the sample pad.
- the assay reagents necessary for performing a binding assay are incorporated into the reagent layer or layers.
- the specific binding assay determination of analyte from a fluid sample typically involves binding among the analyte, a reversibly immobilized labelled reagent, and a binding partner of the analyte, or the analyte or binding analog thereof.
- the labelled reagent comprises the analyte of binding analog thereof, or a binding partner of the analyte, respectively, depending upon the nature of the immobilized reagent, labelled with a detectable chemical group having a detectable chemical or physical property.
- a second reagent or other assay reagents which are similarly capable of interacting with the first reagent to provide a detectable signal, are incorporated into a detection layer in an insolubilized form according to conventional methods well known in the art.
- an assay reaction or interaction involves a labelled reagent comprising a chemical group having a detectable chemical property, such as an enzyme
- a second reagent such as a substrate for the enzyme
- results in the generation of a reaction product which either inherently provides a detectable signal or requires further interaction with another substance or other substances to provide a detectable signal, depending upon the nature of the label of the labelled reagent and the second reagent.
- this labelled reagent can further include a binding site for the second reagent which comprises a binding substance or binding counterpart for the binding site of the labelled reagent. Accordingly, selection of an appropriate binding substance for immobilization in the measurement zone layer necessarily depends upon the selective recognition of the binding site by the binding substance.
- the labelled reagent comprises a ligand moiety which forms a specific binding pair with the binding substance.
- binding pairs for the ligand moiety and the binding substance include such binding pairs as haptens and antibodies, or fragments thereof, to the haptens; biotin and avidin; carbohydrates and lectins; and antibody, or fragment thereof, having an intact binding site for Protein A and Protein A.
- Additional binding pairs include complementary single stranded oligonucleotide sequences; effector molecules and receptor pairs; prosthetic groups and apoproteins; enzyme cofactors and enzymes; polymeric acids and bases; dyes and protein binders; peptides and specific protein binders (e.g., ribonuclease, S-peptide and ribonuclease S protein) ; enzyme inhibitors (reversible and irreversible) , enzymes, and the like.
- the labelled reagent can be selectively immobilized in the measurement zone by binding to an adsorbent material for the labelled reagent, such as an ion exchange material, which acts as the binding substance, which is immobilized in the detection layer.
- an adsorbent material for the labelled reagent such as an ion exchange material, which acts as the binding substance, which is immobilized in the detection layer.
- Other materials may also be employed as a binding substance for the first or labelled reagent provided.
- the fluid sample After the fluid sample has incubated with the reagents for an appropriate predetermined period of time, which time depends upon the particular reaction and is well known to those skilled in the art, the fluid sample flows through the reagent zone to the measurement zone. In the measurement zone, the sample which has reacted with reagents in the reagent zone to form the appropriate products contacts a signal producing system.
- the signal producing system may have one or more components which, in the presence of the product produced in the reagent layer, produce a detectable signal.
- the signal producing system includes all of the reagents required to produce a measurable signal, as well as a developer.
- the developer may include substrates, coenzymes, enhancers, second enzymes, activators, cofactors, inhibitors, scavengers, metal ions, specific binding substances required for binding to signal generating substances, and the like.
- the components of the signal producing system may be bound to the measurement zone such as coenzymes, substances that react with enzymatic products, other enzymes and catalysts, and the like.
- the signal producing system provides a signal detectable by external means, normally by measurement of electromagnetic radiation, desirably by visual examination.
- the signal producing system includes a chromophoric substrate and an enzyme, where the chromophoric substrates are enzymatically converted to dyes which absorb light in the ultraviolet or visible region, phosphors or fluorophores.
- the signal producing system preferably provides a detectable signal related to the amount of analyte originally present in the sample.
- enzymes which involve the production of hydrogen peroxide and the use of the hydrogen peroxide to oxidize a dye precursor to a dye are assayed using enzymes which involve the production of hydrogen peroxide and the use of the hydrogen peroxide to oxidize a dye precursor to a dye.
- Particular combinations include saccharide oxidases, such as glucose and galactose oxidase, or heterocyclic oxidase, such as uricase and xanthine oxidase, coupled with an enzyme which employs the hydrogen peroxide to oxidize a dye precursor, e.g. , a peroxidase such as horseradish peroxidase, lactoperoxidase, and microperoxidase. Additional enzyme combinations are well known to those skilled in the art of clinical assays.
- hydrolases such as alkaline phosphatase and beta- galactosidase.
- hydrolases such as alkaline phosphatase and beta- galactosidase.
- luciferases may be used, such as firefly luciferase and bacterial luciferase.
- the product of the enzyme reaction is usually a dye or fluorescer. These dyes or fluorescers are chosen for their sensitivity to the reaction product as well as for their sensitivity as required for each assay.
- the flow delay means of the present invention comprises a coatable, impregnatable or couplable material which has been coated, impregnated or coupled with a sizing material, i.e., substance which retains fluid for a predetermined period of time, and then permits substantially all of the fluid to flow through the material.
- a sizing material i.e., substance which retains fluid for a predetermined period of time, and then permits substantially all of the fluid to flow through the material.
- the time period that the sample is retained on the flow delay means can be controlled by selecting the sizing material and the amount of this sizing material used to coat or impregnate the material.
- This coating or impregnating process is also referred to as "sizing" the substrate.
- the flow delay means of the present invention can take a variety of forms.
- a fibrous or absorbent material is impregnated with an alkyl ketene dimer or a fatty acid chloride, or coated with a fluorocarbon resin.
- Figure 1 shows how alkyl ketene dimers react with cellulose.
- a fatty acid chloride is reacted with triethylamine and triethylamine hydrochloride to form an alkyl ketene (not isolated) , which dimerizes to form the alkyl ketene dimer.
- this alkyl ketene dimer is reacted with cellulose (paper fibers)
- the alkyl ketene dimer reacts with the hydroxyl group at the end of the cellulose molecule to form a sized paper.
- materials in addition to cellulose are treated.
- glass fibers or polyamide or other synthetic fibers are treated with the alkyl ketene dimers in a similar manner.
- the alkyl ketene dimers can be applied from solution (such as from dichloromethane, ethyl acetate, and the like) or from an aqueous emulsion.
- the precursors to alkyl ketene dimers, the fatty acid chlorides can be attached directly to or merely deposited onto the substrate to be treated.
- Sizing of the fibrous or absorbent material works because long, hydrophobic fatty acid chains, when deposited onto a relatively hydrophilic surface such as paper or glass, spread out and create a moisture-impervious shield on the surface. This shield can be thought of as an umbrella.
- alkyl ketene dimers have been found to provide valuable flow delay for fluid samples.
- alkyl ketene dimers are palmitoyl ketene dimer (C 16 ) , saturated fatty acid ketene dimers such as stearoyl (C 18 ) , behenoyl (C 22 ) , and myristoyl (C 14 ) .
- alkyl ketene dimers of fatty acids having at least 14 carbon atoms, and up to about 30 carbon atoms, are preferred for the present invention.
- Lower molecular weight alkyl ketene dimers such as capryloyl (C 8 ) , lauroyl (C i2 ) , do not provide the degree of flow delay necessary for use in assays of fluid samples.
- fatty acid ketene dimers of equal chain length but containing at least one site of unsaturation do not provide the degree of flow delay required, as shown in Figures 7 and 8 and Table 1.
- the fatty acid chlorides for use in the present invention as sizing materials are saturated fatty acid chlorides such as palmitoyl chloride (C 16 ) , stearoyl chloride (C 18 ) , benenoyl chloride (C 22 ) and myristoyl chloride (C 14 ) .
- saturated fatty acid chlorides such as palmitoyl chloride (C 16 ) , stearoyl chloride (C 18 ) , benenoyl chloride (C 22 ) and myristoyl chloride (C 14 ) .
- palmitoyl chloride C 16
- stearoyl chloride C 18
- benenoyl chloride C 22
- myristoyl chloride C 14
- Type HC Cone. mM Average Sizing satn (mg/mL) flow delay time
- Palmitoleoyl 2.50 5.29 2
- Palmitoleoyl 1.00 2.12 2
- Figure 2 shows the fatty chains 21 of an alkyl ketene dimer sweeping the surface of the matrix 22 which has been impregnated therewith.
- the degree of sizing is determined by the density of the fatty chains on the surface of the substrate.
- Fluorocarbon resins create a similar environment. However, fluorocarbon resins do not usually rely upon an anchoring site for attachment. Instead, these resins bloom to the surface of the material onto which they are deposited, where they remain to create a moisture-impervious shield. Fluorocarbon resin sizes have been used extensively for treating apparel fabrics, upholstery fabrics, and carpeting to provide moisture- and stain- resistance. Iri this case, the absorption of fluids onto the surface treated is slowed by the sizing agent. After a given retention time, the fluid flows into the adjoining bibulous layer, which absorbs the fluid very quickly. This sizing, then, acts in the same way as a valve, in that the fluid is kept out for a certain period of time, and then is all permitted to flow into the adjoining layer.
- the fluorocarbon resins that can be used in the present invention are those which are conventionally used for treating fabric (both apparel and upholstery) for water-resistance.
- the formulations specifically used in the present inventions, FX- 327 and FC-3537, are trade secret formulations of the 3M Company; it is known that the primary ingredient in these formulations is fluoropolymers.
- These fluoropholymers can be substantially completely hydrophobic or the fluoropolymers can have both hydrophobic and hydrophilic moieties. Further characteristics of these materials can be obtained by appropriate physical and chemical assays known to those skilled in the art, including but not limited to average molecular weight of the fluorocarbon resins, degree of fluorination and the like.
- Fluoromonomers were found to be unacceptable as flow delay treatments. Several perfluorinated monomers were coated onto glass fiber pads, but these compounds did not demonstrate any sizing capability. Thus, fluoropolymers rather than monomers are required for the type of sizing needed to provide a valve- like action.
- the fluoropolymers used for sizing do not dissolve in the fluid stream, unlike soluble polymers such as polyvinyl pyrrolidone and polyethylene glycol, which do dissolve in the fluid stream after a predetermined time. Although the fluoropolymers delay flow through a temporary barrier layer, there is no concomitant slowdown in overall flow time in the device below a dosage of about 0.008 ⁇ g/pad of fluorocarbon size. Table 4 and Figure 3 illustrate this feature.
- FIG 3 illustrates how fluorocarbon resins provide a water-resistant shield to a substrate.
- the fluorocarbon resins 31 do not chemically attach functional groups on the surface of the matrix 32, but instead merely bloom to the surface of the matrix and reside there due to their hydrophobic nature.
- hydrophilic and hydrophobic regions or domains There are commercial compounds which contain alternating hydrophilic and hydrophobic regions or domains.
- DuPont ZONYL which has a hydrophilic structure and a fluorinated hydrophobic tail.
- the hydrophilic domains are "anchored” physicochemically rather than covalently in the hydrophilic matrix, while the hydrophobic domains remain at the surface. This anchoring comes from the alternating domains seeking regions which are compatible: the philic portions assemble in the philic glass- fiber or paper milieu.
- the phobic portions which do not find compatible surroundings, exit to the surface ("bloom") and remain at the surface.
- Figure 4 illustrates how compounds with both hydrophilic 41 and hydrophobic 42 domains reside comfortably and securely at the matrix surface 43.
- candidate flow materials may be evaluated for suitability by applying them to a substrate and measuring flow delay and total flow time before and after application (see Examples) .
- Figure 5 illustrates representative configurations of flow delay means according to the present invention.
- the flow delay pad 54 stops the flow of the fluid for a pre-determined incubation period. After this incubation period, the fluid is permitted to flow to the post-reaction zone 55.
- Figure 6 illustrates another configuration for an assay device using the flow delay layer of the present invention.
- a sample 61 first contacts and absorbent pad 62 which draws the sample into the assay device.
- the sample then contacts the reagent layer 63 and is retained there for a predetermined time by the flow delay layer. After the predetermined time, the flow delay layer permits the sample to flow through to the measurement zone 65.
- the pad forming the flow-delay layer is prepared by optionally first dosing it with lactose, followed by drying.
- the lactose-treated pads are then dosed with an ethyl acetate solution of palmitoyl ketene dimer, either by micropipet, IVEK pump, syringe pump, dropping, or other compatible method.
- the method of dosing is not critical to the" formation of the pads.
- the pads are then dried in an oven at 100°C for about 30 minutes to develop the size.
- the range of sizing material per pad can range from about 0.0001 microgram to about 100 micrograms per pad, although more or less of the sizing material can be added to the pad if different flow times are desired.
- One example of flow control means is about 5.5 microliter of a 5 mg/mL ethyl acetate solution of palmitoyl ketene dimer on each pad (0.2" x 0.3"), i.e., 27.5 micrograms of palmitoyl ketene dimer per pad.
- the amount of flow control means is varied depending upon how long a flow delay time is required to give an accurate test. For example, while a two minute flow delay is sufficient for total cholesterol, HDL requires a longer flow delay time, of approximately 3.5 minutes.
- the amount of sizing agent is varied so as to vary the amount of flow delay desired.
- the pads can be made from materials such as glass or synthetic fibers.
- the pads can be woven or nonwoven.
- the fibers from which the pads are made are preferably hydrophilic, either by the nature of the fibers themselves or by post-treatment of the fibers.
- the fiber size is not material.
- the mesh or pore size of the pad can average about 200 microns, with a preferred range being from about 20 to about 500 microns.
- Flow delay can be effected in assay devices by a variety of means. As noted previously, many workers have tried means for delaying flow for a number of different purposes. Some of these means include dissolution, swelling, chemical reaction, and sizing. Experiments were conducted to compare the various flow delay techniques. Dissolution
- Support matrices were impregnated with water soluble compounds such as polyethylene glycol or sugars (sucrose, mannitol, sorbitol, and the like) to form a flow delay pad.
- water soluble compounds such as polyethylene glycol or sugars (sucrose, mannitol, sorbitol, and the like) to form a flow delay pad.
- the fluid was stopped upon reaching the flow delay pad, and the time required to dissolve the compounds so that the fluid can penetrate and continue flowing through the pad is the delay mechanism.
- Many of these trials gave 5-90 second flow delays, but the delay times were unreliable.
- the overall flow rate slowed due to the increase of viscosity of the fluid from dissolving the flow delay compounds.
- Swelling Compounds which swell upon contact with water can be used to coat a flow delay pad.
- examples of such compounds include shellac gum.
- these swelling compounds were found to be effective for delaying flow, the swollen barrier formed by the swollen compound restricted the total flow rate excessively. Restricting the flow rate poses the danger that insufficient sample will flow through the pad to effect the remaining reactions which cause the detectable signal, thus providing an invalid assay.
- Chemical reaction Chemical reactions such as a proteolytic enzyme acting on a proteinaceous source, can be used to delay flow through a pad. Gelatins were coated onto pads to provide a flow delay barrier. Protease in the reagent zone slowly broke down the gelatin film, opening the barrier for fluid flow to continue. Unfortunately, the flow delay pads prepared in this manner gave very inconsistent delay times. As with dissolution, this technique introduced extraneous matter into the sample. Sizing
- the pad used was a glass fiber pad a glass fiber filter with a mean pore size of 1.2 microns and a thickness of about 700 microns. These pads were pretreated with lactose as described above.
- the sizing materials of the present invention unlike materials which attempt to delay flow by dissolution, swelling or chemical reaction, provide reproducibility of results without affecting the viscosity or chemical composition of the sample. There is no diffusion of the detection signal produced by the sample when the sizing materials of the present invention are used to delay the flow.
- flow delay means of the present invention may be, if desired, combined with other methods of flow delay.
- the substrates to be used as flow delay pads can be treated in two principal ways:
- the present invention is not limited to any particular method of applying the flow delay material to the substrate.
- alkyl ketene dimer sizing composition for this example, the alkyl ketene dimer used was palmitoyl (C 16 )ketene dimer, a typical fatty acid ketene dimer.
- the ketene dimer was prepared by dissolving 27.5 grams palmitoyl chloride in 200 mL ethyl acetate in a 500 mL Erlenmeyer flask. Then, 10.1 grams triethylamine was dissolved in 50 mL ethyl acetate and placed into an addition funnel. The solution of triethylamine was dripped slowly into the stirring acid chloride solution.
- a stock solution was prepared by dissolving one gram of palmitoyl ketene dimer in 25 mL ethyl acetate. This stock solution was diluted to appropriate levels, i.e., to a level that permits mechanical dispensing of the solution onto pads in a precise manner. Given pads of a size approximately 0.2" x 0.3", no more than 6 microliters of solution should be applied to each pad so that the solution does not seep beyond the confines of the pad itself. To obtain 25 micrograms of size on the pad, the stock solution is diluted to a level such that 4 to 6 microliters deposit 25 micrograms of sizing material.
- the actual concentration of the dosing solution is immaterial as long as the solution can readily be mechanically dispensed onto the pad without seeping out of the pad; the amount of sizing applied, i.e., grams of sizing per pad, is the critical amount in effecting flow delay.
- Palmitoyl ketene dimer was dissolved in 25 mL ethyl acetate. This stock solution was diluted to appropriate levels to provide flow delay, and six microliter aliquots of a chosen dilution were applied to pre-cut glass fiber filter pads which had been pre-treated with lactose.
- the pads were cut from Ahlstronm Filtration grade 100 glass-fiber sheets.
- the pads were pre-treated with lactose by dosing each pad with a 36.4 mg/mL solution of d-lactose in water so that the final dosage was 200 micrograms lactose per pad.
- the pads were dried in a 100'C oven for 30 minutes and cooled in a desiccated atmosphere. The pads were installed in a disposable assay device for testing.
- alkyl ketene dimer sizes readily react with the hydroxy groups on cellulose. Consequently, paper is readily impregnated with alkyl ketene dimers by coating the paper with a solution of the alkyl ketene dimer, evaporating the solvent, and curing the sizing with heat, such as for thirty minutes at 100'C. The sized and cured paper was then subjected to extensive extraction with solvent such as dichlorome hane or ethyl acetate. This extraction is readily accomplished by soaking the paper in the solvent, or by Soxhlet extraction. This is a procedure conventionally used in the paper industry to show that size is chemically anchored to paper. Because none of the alkyl ketene dimer was extracted from the paper, it was concluded that the sizing molecule was covalently attached to the surface of the paper.
- solvent such as dichlorome hane or ethyl acetate
- Alkyl ketene dimer was applied to glass fiber pads as described in Example 1 to yield pads having different amounts of alkyl ketene dimer applied thereto. After the pads had been prepared, they were combined with an assay device as shown in Figure 6, and a sample of whole blood was applied thereto. Table 3 below shows that an increase in the amount of sizing added to the flow-delay pad results in an increase in the flow delay time without a concomitant increase in the total flow time.
- Flow delay time is the time interval from fie absorption of whole blood into the absorbent pad, its flow through the reagent layer, and its incubation at the reagent layer, to the point when it is first detected at the measurement zone.
- the “Total flow time” is the time required for the sample to flow through the measurement zone.
- a solution of palmitoyl chloride was prepared by dissolving 0.5 g palmitoyl chloride in 5 mL dichloromethane.
- a 1/8 section of the NaOH-treated filter paper was soaked for 15 minutes in the palmitoyl chloride solution, then washed thoroughly with dichloromethane to remove any unreacted palmitoyl chloride.
- the amount of fatty sizing material attached to the paper is easily adjusted by adjusting the concentration of the palmitoyl chloride solution.
- the protonated form of the paper can be regenerated by soaking in a dilute acid solution.
- fatty acid chloride was coated directly onto a paper from a dilute solution in dichloromethane. Although this material developed sizing properties, it required a longer time to develop these sizing properties. It was postulated that the sizing properties required longer to develop because the reaction of acid chloride with available hydroxy groups on the paper is slower without the presence of the additional base on the protonated paper.
- fluoroaliphatic resins were applied to substrates such as paper or glass fiber pads.
- the levels of fluoroaliphatic resin useful in flow delay pads were in the range of thousandths of a microgram, e.g., from 0.0005 microgram to about 0.01 microgram per pad.
- the pad dimensions for this amount of resins were 0.2 inch x 0.3 inch.
- Each pad weighed approximately 1 mg. Thus, dosage was calculated either as the amount of sizing agent per area of pad or amount of sizing agent per gram of pad material.
- the ranges of resin used were from about 0.005 microgram/in 2 to about 0.2 microgram/in 2 .
- the fluorocarbons are readily obtained in either aerosol or liquid form as products for treating fabric or carpets, such as 3M FX-327, FC-3537, Scotchgard ⁇ fabric treatment spray, and similar formulations.
- the product was sprayed directly onto the substrate, or was first diluted with an appropriate solvent.
- Liquid fluorocarbon resins were diluted to provide from about 0.005 microgram to about 0.001 microgram of fluorocarbon resin per pad.
- Suitable solvents are ethyl acetate, chloroform, dichloromethane, hexanes, etc, depending upon the sizing agent's particular solubility characteristics.
- the method for dilution and application by imbibition for fluorocarbon sizes was identical to that used for alkyl ketene dimer sizes.
- Example 1 was repeated using a pad impregnated with a fluorocarbon resin as described above for the flow delay material.
- Table 4 shows that, for fluorocarbon resins, there is a useful concentration of resin per pad, generally up to about 0.008 ⁇ g resin per pad. Beyond that concentration of fluorocarbon resin per pad, there is a rapid increase in flow delay time, and total flow time, for small increases in dosage of fluorocarbon sizing.
- Example 4 Other sizing materials
- sizing materials such as fatty (C 12 -C 24 ) acids, fatty (C 12 -C 24 ) alcohols, alkenyl succinic anhydrides, were applied to the desired pad material from dilute solutions of solvents appropriate to the compound being applied: ethyl acetate, dichloromethane, chloroform, trichloroethylene, acetone, toluene, methanol, ethanol, hexanes, and the like.
- the dilutions of fatty alcohols, fatty acids and alkenyl succinic anhydrides are comparable to those used for palmitoyl ketene dimer. Although these materials were somewhat effective in delaying flow for a predetermined time, they were not as effective as the materials described above.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95911120A EP0748446A1 (en) | 1994-03-01 | 1995-03-01 | Method and apparatus for flow control |
JP7528537A JPH10501060A (en) | 1994-03-01 | 1995-03-01 | Method and apparatus for flow control |
AU18838/95A AU682940B2 (en) | 1994-03-01 | 1995-03-01 | Method and apparatus for flow control |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/203,565 | 1994-03-01 | ||
US08/203,565 US5447689A (en) | 1994-03-01 | 1994-03-01 | Method and apparatus for flow control |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995033994A1 true WO1995033994A1 (en) | 1995-12-14 |
Family
ID=22754506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/002431 WO1995033994A1 (en) | 1994-03-01 | 1995-03-01 | Method and apparatus for flow control |
Country Status (6)
Country | Link |
---|---|
US (1) | US5447689A (en) |
EP (1) | EP0748446A1 (en) |
JP (1) | JPH10501060A (en) |
AU (1) | AU682940B2 (en) |
CA (1) | CA2183762A1 (en) |
WO (1) | WO1995033994A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5660798A (en) * | 1993-04-20 | 1997-08-26 | Actimed Laboratories, Inc. | Apparatus for red blood cell separation |
US5853894A (en) * | 1997-02-03 | 1998-12-29 | Cytonix Corporation | Laboratory vessel having hydrophobic coating and process for manufacturing same |
US6495624B1 (en) * | 1997-02-03 | 2002-12-17 | Cytonix Corporation | Hydrophobic coating compositions, articles coated with said compositions, and processes for manufacturing same |
US8653213B2 (en) | 1997-02-03 | 2014-02-18 | Cytonix, Llc | Hydrophobic coating compositions and articles coated with said compositions |
US7268179B2 (en) * | 1997-02-03 | 2007-09-11 | Cytonix Corporation | Hydrophobic coating compositions, articles coated with said compositions, and processes for manufacturing same |
US7713703B1 (en) | 2000-11-13 | 2010-05-11 | Biosite, Inc. | Methods for monitoring the status of assays and immunoassays |
US6194222B1 (en) * | 1998-01-05 | 2001-02-27 | Biosite Diagnostics, Inc. | Methods for monitoring the status of assays and immunoassays |
US6120464A (en) * | 1998-10-16 | 2000-09-19 | Integ, Inc. | Needle assembly for fluid sampler |
ATE538860T1 (en) | 2000-08-21 | 2012-01-15 | Hokuetsu Kishu Paper Co Ltd | FILTER MEDIUM FOR AIR FILTRATION AND METHOD FOR PRODUCING THE SAME |
US6698510B2 (en) * | 2001-04-24 | 2004-03-02 | Mide Technology Corporation | Article and method for temperature regulation using a thermosensitive reactive hydrogel material |
US7732047B2 (en) * | 2001-05-01 | 2010-06-08 | Ocv Intellectual Capital, Llc | Fiber size, sized reinforcements, and articles reinforced with sized reinforcements |
US7585563B2 (en) * | 2001-05-01 | 2009-09-08 | Ocv Intellectual Capital, Llc | Fiber size, sized reinforcements, and articles reinforced with such reinforcements |
US6884592B2 (en) * | 2001-09-05 | 2005-04-26 | Lifescan, Inc. | Devices for analyte concentration determination and methods of manufacturing and using the same |
US20030211006A1 (en) * | 2002-05-10 | 2003-11-13 | Suyue Qian | Multilayer reagent test strips that include at least one fluid flow control layer and methods for using the same |
FI122944B (en) * | 2008-06-06 | 2012-09-14 | Metsaeliitto Osuuskunta | Procedure for protecting wood |
DE102009029194A1 (en) | 2009-09-04 | 2011-04-07 | Kimberly-Clark Worldwide, Inc., Neenah | Separation of colored substances from aqueous liquids |
US9220646B2 (en) | 2012-03-30 | 2015-12-29 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with improved stain decolorization |
WO2014081460A1 (en) * | 2012-11-20 | 2014-05-30 | Kisner Mark | Chemical sequencing and control to expand and enhance detection capabilities utilizing a colorimetric test |
US9237975B2 (en) | 2013-09-27 | 2016-01-19 | Kimberly-Clark Worldwide, Inc. | Absorbent article with side barriers and decolorizing agents |
US10273463B2 (en) * | 2014-10-16 | 2019-04-30 | International Paper Company | Chemiluminescent wetness indicator for absorbent products |
CN108463726B (en) * | 2016-01-15 | 2021-06-08 | 帝斯曼知识产权资产管理有限公司 | Method for detecting an analyte |
JP7066726B2 (en) * | 2017-01-27 | 2022-05-13 | ベクトン・ディキンソン・アンド・カンパニー | Vertical flow assay device for detecting glucose concentration in fluid samples |
IL279365B2 (en) | 2018-06-29 | 2024-01-01 | Int Paper Co | Synthesis of coelenterazine |
US11078200B2 (en) | 2018-06-29 | 2021-08-03 | International Paper Company | Synthesis of coelenterazine |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4241136A (en) * | 1979-03-05 | 1980-12-23 | Owens-Corning Fiberglas Corporation | Glass fiber size composition and process |
EP0160916A2 (en) * | 1984-04-27 | 1985-11-13 | Fuji Photo Film Co., Ltd. | Part of an analytical element for the analysis of a solid in a liquid sample |
EP0254202A1 (en) * | 1986-07-15 | 1988-01-27 | Fuji Photo Film Co., Ltd. | Method of preparing integral multilayer analytical element |
EP0341509A1 (en) * | 1988-04-28 | 1989-11-15 | Japan Pmc Corporation | Sizing composition and sizing method |
EP0354397A2 (en) * | 1988-08-06 | 1990-02-14 | Bayer Ag | Treatment of wool and polyamide fibres |
EP0619289A1 (en) * | 1993-03-26 | 1994-10-12 | Hercules Incorporated | Process for the manufacture of alkyl ketene dimers by dimerization with tertiary amines |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3723064A (en) * | 1971-07-26 | 1973-03-27 | L Liotta | Method and device for determining the concentration of a material in a liquid |
US4038485A (en) * | 1976-03-18 | 1977-07-26 | Miles Laboratories, Inc. | Test composition, device, and method |
CA1095819A (en) * | 1977-01-14 | 1981-02-17 | Eastman Kodak Company | Element for analysis of liquids |
US4310399A (en) * | 1979-07-23 | 1982-01-12 | Eastman Kodak Company | Liquid transport device containing means for delaying capillary flow |
JPS603367B2 (en) * | 1979-10-09 | 1985-01-28 | 旭化成株式会社 | Leukocyte separation method and leukocyte separation material |
JPS5782766A (en) * | 1980-11-11 | 1982-05-24 | Konishiroku Photo Ind Co Ltd | Amynological measuring element |
DE3118381A1 (en) * | 1981-05-09 | 1982-11-25 | Boehringer Mannheim Gmbh, 6800 Mannheim | MULTILAYER TEST MEANS FOR DETECTING A COMPONENT OF A LIQUID SAMPLE |
JPS57200862A (en) * | 1981-06-05 | 1982-12-09 | Fuji Photo Film Co Ltd | Mutilayer analysis element utilizing unique binding reaction |
US4549952A (en) * | 1982-11-22 | 1985-10-29 | Eastman Kodak Company | Capillary transport device having means for increasing the viscosity of the transported liquid |
US4522786A (en) * | 1983-08-10 | 1985-06-11 | E. I. Du Pont De Nemours And Company | Multilayered test device for detecting analytes in liquid test samples |
US4522923A (en) * | 1983-10-03 | 1985-06-11 | Genetic Diagnostics Corporation | Self-contained assay method and kit |
US4618476A (en) * | 1984-02-10 | 1986-10-21 | Eastman Kodak Company | Capillary transport device having speed and meniscus control means |
US4837395A (en) * | 1985-05-10 | 1989-06-06 | Syntex (U.S.A.) Inc. | Single step heterogeneous assay |
US4963498A (en) * | 1985-08-05 | 1990-10-16 | Biotrack | Capillary flow device |
DE3530993A1 (en) * | 1985-08-30 | 1987-03-05 | Miles Lab | TEST STRIP WITH DETERMINABLE SAMPLE CAPACITY |
US4889797A (en) * | 1986-05-28 | 1989-12-26 | Fuji Photo Film Co., Ltd. | Dry analytical element having a spread control area for assaying enzyme activity |
US4959305A (en) * | 1986-06-18 | 1990-09-25 | Miles Inc. | Reversible immobilization of assay reagents in a multizone test device |
DE3630999A1 (en) * | 1986-09-12 | 1988-03-17 | Boehringer Mannheim Gmbh | MULTI-LAYER TEST CARRIER |
US4774192A (en) * | 1987-01-28 | 1988-09-27 | Technimed Corporation | A dry reagent delivery system with membrane having porosity gradient |
US4959324A (en) * | 1989-03-16 | 1990-09-25 | Chemtrak, Inc. | Sample pad assay initiation device and method of making |
US4923680A (en) * | 1987-09-18 | 1990-05-08 | Eastman Kodak Company | Test device containing an immunoassay filter with a flow-delaying polymer |
FR2630827B1 (en) * | 1988-04-28 | 1994-06-03 | Oris Ind | APPARATUS AND METHOD FOR QUICK QUALITATIVE AND QUANTITATIVE DETERMINATION OF THE PRESENCE OF A REACTIVE LIGAND IN A FLUID |
US5051237A (en) * | 1988-06-23 | 1991-09-24 | P B Diagnostic Systems, Inc. | Liquid transport system |
US5071675A (en) * | 1989-03-20 | 1991-12-10 | Weyerhaeuser Company | Method of applying liquid sizing of alkyl ketene dimer in ethanol to cellulose fibers entrained in a gas stream |
US5207988A (en) * | 1989-07-06 | 1993-05-04 | The Cleveland Clinic Foundation | Apparatus for detecting and quantifying clot lysis and establishing optimum medication and dosages |
US5185127A (en) * | 1989-09-21 | 1993-02-09 | Becton, Dickinson And Company | Test device including flow control means |
US5104812A (en) * | 1989-11-27 | 1992-04-14 | Syntex (U.S.A.) Inc. | Device and method for interrupting capillary flow |
US5213965A (en) * | 1990-07-16 | 1993-05-25 | Cholestech Corporation | Solid-phase precipitation assay device |
-
1994
- 1994-03-01 US US08/203,565 patent/US5447689A/en not_active Expired - Fee Related
-
1995
- 1995-03-01 JP JP7528537A patent/JPH10501060A/en active Pending
- 1995-03-01 AU AU18838/95A patent/AU682940B2/en not_active Ceased
- 1995-03-01 WO PCT/US1995/002431 patent/WO1995033994A1/en not_active Application Discontinuation
- 1995-03-01 EP EP95911120A patent/EP0748446A1/en not_active Withdrawn
- 1995-03-01 CA CA002183762A patent/CA2183762A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4241136A (en) * | 1979-03-05 | 1980-12-23 | Owens-Corning Fiberglas Corporation | Glass fiber size composition and process |
EP0160916A2 (en) * | 1984-04-27 | 1985-11-13 | Fuji Photo Film Co., Ltd. | Part of an analytical element for the analysis of a solid in a liquid sample |
EP0254202A1 (en) * | 1986-07-15 | 1988-01-27 | Fuji Photo Film Co., Ltd. | Method of preparing integral multilayer analytical element |
US4966784A (en) * | 1986-07-15 | 1990-10-30 | Fuji Photo Film Co., Ltd. | Method of preparing integral multilayer analytical element |
EP0341509A1 (en) * | 1988-04-28 | 1989-11-15 | Japan Pmc Corporation | Sizing composition and sizing method |
EP0354397A2 (en) * | 1988-08-06 | 1990-02-14 | Bayer Ag | Treatment of wool and polyamide fibres |
EP0619289A1 (en) * | 1993-03-26 | 1994-10-12 | Hercules Incorporated | Process for the manufacture of alkyl ketene dimers by dimerization with tertiary amines |
Also Published As
Publication number | Publication date |
---|---|
US5447689A (en) | 1995-09-05 |
CA2183762A1 (en) | 1995-12-14 |
JPH10501060A (en) | 1998-01-27 |
AU1883895A (en) | 1996-01-04 |
EP0748446A1 (en) | 1996-12-18 |
AU682940B2 (en) | 1997-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5447689A (en) | Method and apparatus for flow control | |
EP0291194B2 (en) | Immunoassays and devices therefor | |
JP2504923B2 (en) | Immunological measurement method | |
US5656503A (en) | Test device for detecting analytes in biological samples | |
CA1236011A (en) | Assay method for whole blood samples | |
US5416000A (en) | Analyte immunoassay in self-contained apparatus | |
US5714340A (en) | Immunoassay elements having a receptor zone | |
JPS6285866A (en) | Heterogeneous immunity testing method utilizing horizontal separation in analysis element | |
US20030215358A1 (en) | Liquid permeable composition in dry reagent devices | |
EP0236768B1 (en) | Multi-layered element for quantitative analysis of immuno-reactant | |
JPS63159761A (en) | Immunological chromatographic method and device | |
JP2576910B2 (en) | Immunoassay element and immunoassay method | |
EP0252750B1 (en) | Composition and analytical element having stabilized peroxidase | |
WO2003023051A2 (en) | Lateral flow test format for enzyme assays | |
EP0056055A1 (en) | Immunosubstrate and immunoadsorptive surface coating for solid-phase immunosubstrate | |
CA1285872C (en) | Binder composition and analytical element having stabilized peroxidase in layer containing the composition | |
EP0226465A2 (en) | Integral multilayer analytical element | |
US5338513A (en) | Test carrier for the analytical determination of a component of a liquid sample | |
US5266460A (en) | Method of preparing immunological analytical element | |
US5556743A (en) | Method for immobilizing dye on substrates | |
EP0298473B1 (en) | Analytical element for analysis of whole blood | |
EP0254457A1 (en) | Analytical element having spread control zone | |
JPS60249057A (en) | One-stage heterogeneous assay | |
EP0253581A1 (en) | Analytical element having water-soluble polymers and determinations using same | |
CA2062176A1 (en) | Use of the gravure process for coating thin film layers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA FI JP MX NO |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2183762 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995911120 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1995911120 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995911120 Country of ref document: EP |